|
Total (n=830) |
AF free (n=757) |
Incident AF (n=73) |
P-value |
Age (years) |
62.1 (SD 11.6) |
61.5 (SD 11.5) |
68.4 (SD 10.9) |
<0.001 |
Male gender |
631/830 (76.0%) |
580/757 (76.6%) |
51/73 (69.9%) |
0.197 |
BMI (kg/m2) |
26.9 (SD 3.7) |
26.9 (SD 3.7) |
26.4 (SD 3.5) |
0.126 |
Current smoker |
402/827 (48.6%) |
375/755 (49.7%) |
27/72 (37.5%) |
0.048 |
Diabetes |
89/829 (10.2%) |
77/756 (10.2%) |
12/73 (16.4%) |
0.099 |
Hypertension |
276/830 (33.3%) |
251/757 (33.2%) |
25/73 (34.2%) |
0.850 |
Hypercholesterolaemia |
214/829 (25.8%) |
195/756 (25.8%) |
19/73 (26.0%) |
0.965 |
Killip Class >1 |
96/821 (11.7%) |
78/749 (10.4%) |
18/72 (25.0%) |
<0.001 |
Previous MI |
68/828 (8.2%) |
62/755 (8.2%) |
6/73 (8.2%) |
0.998 |
Previous PCI |
68/830 (8.2%) |
65/757 (8.3%) |
5/73 (6.8%) |
0.661 |
Previous CABG |
12/830 (1.4%) |
11/757 (1.5%) |
1/73 (1.4%) |
>0.99* |
Previous stroke |
15/830 (1.8%) |
151/757 (2.0%) |
0/73 (0%) |
0.634* |
Systolic BP (mm Hg) |
130.9 (SD 24.1) |
131.3 (SD 23.8) |
126.2 (SD 24.6) |
0.143 |
Diastolic BP (mm Hg) |
76.6 (SD 15.0) |
76.8 (SD 14.8) |
74.3 (SD 16.1) |
0.306 |
Tirofiban study medication |
406/830 (48.9%) |
369/757 (48.7%) |
37/73 (50.7%) |
0.752 |
Culprit Vessl |
|
|
|
0.997 |
Culprit Vessel RCA |
390/821 (47.5%) |
355/748 (47.5%) |
35/73 (47.9%) |
|
Culprit Vessel LAD |
340/821 (41.4%) |
310/748 (41.4%) |
30/73 (41.1%) |
|
Culprit Vessel LCx |
91/821 (11.1%) |
83/748 (11.1%) |
8/73 (11.0%) |
|
TIMI grade flow post PCI <3 |
74/823 (9.0%) |
62/750 (8.3%) |
12/73 (16.4%) |
0.020 |
NT-proBNP baseline (pg/ml) |
589 (SD 1896) |
517 (SD 1490) |
1339 (SD 4178) |
<0.001 |
HScTnT (pg/ml) |
0.380 (SD 1.27) |
0.358 (SD 1.12) |
0.610 (SD 2.32) |
0.008 |
Peak CK-MB (U/l) |
216 (SD 197) |
207 (SD 189) |
303 (SD 245) |
0.001 |
|
Data are presented as mean with their SD between parentheses or fraction with percentages where appropriate. AF: Atrial Fibrillation; BMI: Body Mass Index; MI: Myocardial Infarction; PCI: Percutaneous Coronary Intervention; CABG: Coronary Artery Bypass Grafting; BP: Blood Pressure; RCA: Right Coronary Artery; LAD: Left Anterior Descending Artery; LCx: Left Circumflex Artery; TIMI: Thrombolysis in Myocardial Infarction; TIMI: Thrombolysis in Myocardial Infarction; NT-proBNP: N-terminal pro Brain Natriuretic Peptide; HScTnT: High Sensitive Cardiac Troponin T; CK-MB; Creatine Kinase, MB Isoenzyme. P-value between AF free and incident AF patient groups. |
Table 1: Baseline characteristics. |